Physician profile
Steven L Driver
NPI 1104147628
$1,905.79
in general payments reported to CMS, 2019-2025
11 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $738 · 2020: $46.94 · 2021: $321 · 2022: $207 · 2023: $166 · 2024: $127 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578 · Entertainment: $16.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.71 |
| Entertainment | $16.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $637.01 | 2019-2025 | Mitraclip |
| Abiomed | $412.14 | 2019-2022 | |
| Edwards Lifesciences Corporation | $348.85 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $155.26 | 2025 | |
| Boston Scientific Corporation | $132.20 | 2019-2022 | |
| Current Health, INC. | $77.28 | 2023-2024 | |
| Teleflex LLC | $64.27 | 2024 | Guideliner, Vascband |
| Medtronic Vascular, INC. | $29.66 | 2020 | |
| Siemens Medical Solutions USA, INC. | $19.20 | 2022 | |
| Opsens INC. | $16.12 | 2023 | Optowire |
| Medtronic, INC. | $13.80 | 2023 | Corevalve Evolut R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Driver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.